The Pennsylvania Record reported today that Ross Feller Casey has filed the first personal injury lawsuit involving a testosterone-containing drug in Philadelphia, and one of only a very few brought to date nationwide.
The legal journal reported that the case involves an Alabama man, Robert Hoehl, who suffered a stroke while taking Testim, one of many so-called “Low T” therapy drugs on the market. Among other things, the suit says that Testim caused the stroke and that the maker and co-promoter of the drug—Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC, respectively—used deceptive marketing techniques to promote the drug.
The suit comes on the heels of the FDA’s decision in January to review all Low T drugs based on two recent studies that demonstrated they greatly increased the risks of serious cardiovascular events, including heart attacks and strokes, in men.
Ross Feller Casey is actively investigating other serious injuries reported to the firm by man nationwide who have taken testosterone replacement therapies. The testosterone lawyers at Ross Feller Casey expect to file additional testosterone lawsuits on behalf of those men and their families soon.
For more information, go to http://www.rossfellercasey.com/practice-areas/lowtlawsuit/